<SEC-DOCUMENT>0001558370-25-006220.txt : 20250505
<SEC-HEADER>0001558370-25-006220.hdr.sgml : 20250505
<ACCEPTANCE-DATETIME>20250505070017
ACCESSION NUMBER:		0001558370-25-006220
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250505
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250505
DATE AS OF CHANGE:		20250505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IRADIMED CORP
		CENTRAL INDEX KEY:			0001325618
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				731408526
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36534
		FILM NUMBER:		25910846

	BUSINESS ADDRESS:	
		STREET 1:		1025 WILLA SPRINGS DR.
		CITY:			WINTER SPRINGS
		STATE:			FL
		ZIP:			32708
		BUSINESS PHONE:		4076778022

	MAIL ADDRESS:	
		STREET 1:		1025 WILLA SPRINGS DR.
		CITY:			WINTER SPRINGS
		STATE:			FL
		ZIP:			32708
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>irmd-20250505x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.10.0.1 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 5/1/2025 9:43:12 PM -->
<!-- iXBRL Library version: 1.0.9179.3415 -->
<!-- iXBRL Service Job ID: dde3a5d4-650b-416f-9c8f-a9c5a57684cf -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:irmd="http://iradimed.com/20250505" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:EntityCentralIndexKey" id="Tc_3KoFK2MkSkayLYDGVyHvAg_2_1">0001325618</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:AmendmentFlag" id="Tc_Fhj_rzFGMkac7uhhMqR3JA_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="irmd-20250505.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001325618</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-05</xbrli:startDate><xbrli:endDate>2025-05-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><a id="_a760c329_d2ef_4553_917b_b8539f7d7869"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><b style="font-size:13pt;font-weight:bold;">WASHINGTON, DC 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:DocumentType" id="Narr_f2Rh0WnCDk2HKrE_m3L2JQ"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">CURRENT REPORT PURSUANT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">TO SECTION&#160;13 OR 15(d)&#160;OF THE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><b style="font-size:13pt;font-weight:bold;"> </b><span style="font-size:13pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><span style="font-size:9pt;">Date of report (Date of earliest event reported): </span><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="Narr_YOzAUF8b8E-dlyvu4rxqpw"><b style="font-size:9pt;font-weight:bold;">May 5, 2025</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:23pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:EntityRegistrantName" id="Narr_GmUgadrvnU2fF17iBzsPpg"><b style="font-weight:bold;">IRADIMED CORPORATION</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><i style="font-style:italic;">(Exact name of registrant as specified in its charter)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Narr_MDEpSYTyQkiu6A32Nm2QWg"><b style="font-size:9pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(State or other jurisdiction of incorporation)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><a id="_b8588306_65d7_4a5e_97c8_c76be9b3f6e7"></a><a id="Tc_THxqA-pQR0m4ePbgNqYoJQ_2_0"></a><a id="Tc_uSzBgbyBwE6ZMLVOZl3FSg_2_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:EntityFileNumber" id="Tc_Gy89x8je9EqHZI8jVFq8PA_1_0"><b style="font-size:9pt;font-weight:bold;">001-36534</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:EntityTaxIdentificationNumber" id="Tc_XPqkCR46pkOYJTtE7bb9TQ_1_2"><b style="font-size:9pt;font-weight:bold;">73-1408526</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(Commission File Number)</i></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(IRS Employer Identification No.)</i></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><a id="_c305608f_c33b_49e8_a597_1cf08b2e14fe"></a><a id="Tc_J8pht2NJrkmcjTpBY1b28A_1_0"></a><a id="Tc_OcCupnXMxEKvPCEeJw8gGw_2_0"></a><a id="Tc_i29VcwA-okOvzE1iBH2muQ_2_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:EntityAddressAddressLine1" id="Narr_rndXxqiARUuRfIsn8VpQNA"><b style="font-size:9pt;font-weight:bold;">1025 Willa Springs Dr.</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:EntityAddressCityOrTown" id="Narr_4kl5514mFEa0jHVUf42a5A"><b style="font-size:9pt;font-weight:bold;">Winter Springs</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:EntityAddressStateOrProvince" id="Narr_AP_3tyOyqkmUlKP9iXnURQ"><b style="font-size:9pt;font-weight:bold;">FL</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:EntityAddressPostalZipCode" id="Tc_M3OI336MD0upp-GSCcCUpw_1_2"><b style="font-size:9pt;font-weight:bold;">32708</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(Address of principal executive offices)</i></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(Zip Code)</i></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:CityAreaCode" id="Narr_Pmo3-xmPvE-SNrGsJV6XMA"><b style="font-size:9pt;font-weight:bold;">407</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:LocalPhoneNumber" id="Narr_xCBTYHZ6406gK2m9H8Qxmw"><b style="font-size:9pt;font-weight:bold;">677-8022</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><i style="font-style:italic;">(Registrant&#8217;s telephone number, including area code)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><i style="font-style:italic;">(Former name or former address, if changed since last report)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;text-indent:18.4pt;margin:0pt 0pt 9pt 0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 9pt 18pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_dRms-T1pjkq-Qmjn7V3egQ"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-size:9pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 9pt 18pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_sHgmVo-xLESiFQImnfMY5g"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-size:9pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 9pt 18pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_Es9eBHYCAUuAXawO-lwFyw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-size:9pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 9pt 18pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_mVWeQhlXqk6kZdLAQaFD_w"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;"><span style="font-size:9pt;">Emerging growth company </span><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_OUXgh8BOfEedgdMcldFftA"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><a id="_650d9459_7d8a_4718_8791_c4129576e77d"></a><a id="Tc_Z9FC5f8X1UWluNm2cvoN0Q_1_0"></a><a id="Tc_eNVTXCExDkuuwUeLmqQKOw_1_2"></a><a id="Tc_CQFAX605p0S85qNMJHI-Ew_1_4"></a><a id="Tc_IKFh5jBhek-HhYJwmCKUog_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:20.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:45.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:30.42%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title&#160;of&#160;each&#160;class:</b></p></td><td style="vertical-align:bottom;width:1.85%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:20.43%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading&#160;Symbol</b></p></td><td style="vertical-align:bottom;width:1.85%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:45.43%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered:</b></p></td></tr><tr><td style="vertical-align:top;width:30.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:Security12bTitle" id="Tc_rm_jkERcnkuq3HHcNNccMw_2_0"><span style="font-size:9pt;">Common stock, par value $0.0001</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:20.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:TradingSymbol" id="Tc_-T-9IaphNkSGnnxECrOfnA_2_2"><span style="font-size:9pt;">IRMD</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:45.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w" name="dei:SecurityExchangeName" id="Narr_HNHP4WQkKkSHFQm1e7l26w"><span style="font-size:9pt;">NASDAQ</span></ix:nonNumeric><span style="font-size:9pt;"> Capital Market</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:justify;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_4c0fc824_4398_4d4e_b8ce_df8a43f9034a"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;2.02</b></span>Results of Operations and Financial Condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">On May 5, 2025, IRADIMED CORPORATION issued a press release (the &#8220;Press Release&#8221;) announcing its financial results for the quarter ended March 31, 2025. A copy of the Press Release is furnished as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The information in this Item&#160;2.02, including Exhibit&#160;99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that Section. Furthermore, such information, including Exhibit&#160;99.1, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</p><a id="_a634e12f_c8b3_4557_a799_c6d143513fed"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;9.01</b></span>Financial Statements and Exhibits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:89.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit&#160;No.</b></p></td><td style="vertical-align:bottom;width:89.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:89.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">99.1</p></td><td style="vertical-align:bottom;width:89.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="irmd-20250505xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press release dated May 5, 2025.</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:89.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:89.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page&#160;Interactive Data File (formatted in Inline XBRL and contained in Exhibit&#160;101)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_dc4e31cb_74da_4a23_88c8_2104d10ecf16"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;">SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:99.89%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:5.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:44.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">IRADIMED CORPORATION </b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: May 5, 2025</p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By: </p></td><td style="vertical-align:top;width:44.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/John Glenn </p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: </p></td><td style="vertical-align:top;width:44.3%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">John Glenn</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: </p></td><td style="vertical-align:top;width:44.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>irmd-20250505xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.10.0.134--><!--Created on: 5/1/2025 09:43:11 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:right;text-indent:36pt;margin:0pt 0pt 12pt 396pt;"><b style="font-weight:bold;white-space:pre-wrap;">   Exhibit&#160;99.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="irmd-20250505xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:47.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:325.45pt;"></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IRADIMED CORPORATION Announces First Quarter 2025 Financial Results </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Announces Regular Quarterly Cash Dividend of $0.17 Per Share </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reaffirms Full Year 2025 Revenue and Earnings Guidance</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Reports record revenue of $19.5 million for the first quarter of 2025, an increase of $1.9 million or 11%, compared to the same period in 2024.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Reports GAAP diluted EPS of $0.37 and non-GAAP diluted EPS of $0.42 for the first quarter of 2025, which are increases of 16% and 17%, respectively, compared to the same period in 2024.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Declares a regular quarterly cash dividend of $0.17 per common share for the second quarter of 2025, payable on May 30, 2025.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Winter Springs, Florida, May 5, 2025&#160;&#8211; IRADIMED CORPORATION (the &#8220;Company&#8221;) (NASDAQ: IRMD) announced today its financial results for the three months ended March&#160;31,&#160;<font style="white-space:pre-wrap;">2025. The Company is a leader in developing innovative magnetic resonance imaging (&#8220;MRI&#8221;) compatible medical devices.  The Company is a provider of  (i) non-magnetic intravenous (&#8220;IV&#8221;) infusion pump system and (ii) a non-magnetic patient vital signs monitoring system that are each designed for use during MRI procedures.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">&quot;We are excited to begin 2025 with our fifteenth consecutive quarter of record revenue, achieving $19.5 million in the first quarter, an 11% increase year-over-year. This impressive top-line performance, coupled with a 16% rise year-over-year in diluted EPS, highlights the sustained demand for our innovative products and our team&#39;s dedication to operational excellence. We are also pleased to maintain our quarterly cash dividend at $0.17 per share, underscoring our commitment to delivering value to our shareholders. With our new manufacturing facility on track for completion in July 2025, we are well-positioned to support our planned growth and build upon the momentum of our strong first quarter performance,&quot; said Roger Susi, President and Chief Executive Officer of Iradimed Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">&#8220;For the second quarter of 2025 financial guidance, we expect revenue of $19.7 million to $19.9 million, GAAP diluted earnings per share of $0.37 to $0.40, and non-GAAP diluted earnings per share of $0.41 to $0.44. We reiterate our guidance for the full year 2025, as we expect to report revenue of $78.0 million to $82.0 million, GAAP diluted earnings per share of $1.55 to $1.65, and non-GAAP diluted earnings per share of $1.71 to $1.81,&#8221; <a name="_Hlk149229113"></a>added Mr. Susi.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="color:#080707;">The Company&#8217;s board of directors (the &#8220;Board&#8221;) declared a regular quarterly cash dividend of $0.17 per share of our outstanding common stock, payable on May 30, 2025, to stockholders of record as of the close of business on May 20, 2025. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Three Months Ended March&#160;31,&#160;2025</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">For the three months ended March&#160;31,&#160;2025, the Company reported revenue of $19.5 million, an increase of $1.9 million, compared to $17.6 million for the comparable period of 2024, an increase of 11%. The Company reported net income of $4.7 million, compared to $4.1 million for the comparable period of 2024, an increase of 15% or $0.37 per diluted share for the three months ended March&#160;31,&#160;2025, compared to $0.32 per diluted share for the same period of 2024, an increase of 16%.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="text-decoration-color:#000000;text-decoration-line:none;">For the three months ended March&#160;31,&#160;</font><font style="text-decoration-color:#000000;text-decoration-line:none;white-space:pre-wrap;">2025, the Company reported non-GAAP net income of $5.3 million, which excludes $0.7 million of stock compensation expense, net of tax benefit, compared to $4.6 million, which excludes $0.5 million of stock compensation expense, net of tax benefit, an increase of 15%.  On a non-GAAP basis, net income per diluted share was $0.42 for the three months ended March&#160;31,&#160;2025, compared to $0.36 per diluted share for the comparable period of 2024, an increase of 17%.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Revenue Information</b><font style="text-decoration-color:#000000;text-decoration-line:none;">:</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:40.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:40.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="7" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Devices:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:40.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">MRI Compatible IV Infusion Pump Systems</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 5,999,212</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 5,192,680</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">MRI Compatible Patient Vital Signs Monitoring Systems</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 6,544,679</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 6,461,658</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Ferro Magnetic Detection Systems</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 418,204</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 249,700</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total Devices revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 12,962,095</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 11,904,038</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Amortization of extended warranty agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 560,199</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 487,131</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,947,088</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,013,875</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Services and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 1,041,255</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 1,193,075</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 19,510,637</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 17,598,119</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">For the three months ended March&#160;31,&#160;2025, domestic sales were 82% of total revenue, compared to 76% for the comparable period of 2024. The gross profit margin was constant at 76.1% for the three months ended March&#160;31,&#160;2025 and 2024. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cash Flow from Operations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">For the three months ended March&#160;31,&#160;<font style="white-space:pre-wrap;">2025, cash flow from operations was $4.3 million, compared to $3.9 million for the comparable period of 2024, an increase of 10%.  See the compilation of non-GAAP free cash flow in the table below.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">As construction continues on the Company&#8217;s new facility in Orlando, Florida, the Company anticipates spending approximately $3.0 million in cash from March 31, 2025, until the project&#8217;s expected completion in July 2025. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Guidance</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">For the second quarter of 2025 financial guidance, the Company expects revenue of $19.7 million to $19.9 million, and GAAP diluted earnings per share of $0.37 to $0.40, and non-GAAP diluted earnings per share of $0.41 to $0.44. For the full year 2025, the Company expects to report revenue of $78.0 million to $82.0 million, GAAP diluted earnings per share of $1.55 to $1.65, and non-GAAP diluted earnings per share of $1.71 to $1.81.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="white-space:pre-wrap;">The Company&#8217;s non-GAAP diluted earnings per share guidance excludes stock-based compensation expense, net of tax expense.  The Company expects stock-based compensation expense, net of tax, to be approximately $2.6 million and $0.6 million for the full&#160;year and second quarter of 2025, respectively.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Non-GAAP Financial Measures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="white-space:pre-wrap;">The Company believes using Non-GAAP net income, earnings per share, and free cash flow is helpful to our investors. These measures, which we refer to as our non-GAAP financial measures, are not prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).  These non-GAAP measures are intended to provide the reader with additional supplemental perspectives on operating results, performance trends, and financial condition. Non-GAAP financial measures are not a substitute for GAAP measures; they should be read and used in conjunction with the Company&#8217;s GAAP financial information. Because non-GAAP financial measures presented in this release are not measurements determined in accordance with GAAP and are susceptible to varying calculations, these non-GAAP financial measures, as presented, may not be comparable to other similarly titled measures presented by other companies.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">We calculate non-GAAP net income as net income excluding:</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">(1)&#160;Stock-based compensation expense, net of tax. Because of varying available valuation methodologies, subjective assumptions, and the variety of equity instruments that can impact a company&#8217;s non-cash expenses, we believe that providing non-GAAP financial measures that exclude stock-based compensation expense allows for meaningful comparisons between our operating results from period to period; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">(2)&#160;Operating expenses, net of tax, that we believe are not indicative of the Company&#8217;s ongoing core operating performance and; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">(3)&#160;Infrequent income tax items are considered based on their nature and are excluded from the provision for income taxes as these costs or benefits are not indicative of our normal or future provision for income taxes. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">We calculate free cash flow as net cash provided by operating activities, less net cash used in investing activities for the development of internal software and purchases of property and equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">We consider free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by our business that can be used for strategic opportunities, including investing in our business, making strategic acquisitions, strengthening our balance sheet and returning cash to our stockholders through various means.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Our non-GAAP financial measures are important tools for financial and operational decision-making and for evaluating our ongoing core operating results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">A reconciliation of the non-GAAP financial measures used in this release to the most comparable GAAP measures for the respective periods can be found in the table later in this release immediately following the condensed statements of operations. These non-GAAP financial measures should not be considered in isolation or as a substitute for a measure of the Company&#8217;s operating performance or liquidity prepared in accordance with GAAP and are not indicative of net income or cash provided by operating activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Conference Call</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company has scheduled a conference call to discuss this release beginning at 9:00 a.m.&#160;Eastern Time, May 5, 2025. Individuals interested in listening to the conference call may do so by registering here, <u style="color:#0000ff;text-decoration-line:underline;text-decoration-style:solid;">https://register-conf.media-server.com/register/BI1cddc009ba2b427a81ea445f5669adff</u><font style="color:#0000ff;">. </font>Once registered a dial-in number, a unique PIN, and instructions will be provided to participants. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The conference call will also be available in real-time via the Internet at <u style="color:#0000ff;text-decoration-color:#0000ff;text-decoration-line:underline;text-decoration-style:solid;">http://www.iradimed.com/en-us/investors/events/</u>. A recording of the call will be available on the Company&#8217;s website following the call&#39;s completion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:11pt;margin:0pt 0pt 12pt 0pt;">About IRADIMED CORPORATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt 0pt 12pt 0pt;">IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging (&#8220;MRI&#8221;) compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt 0pt 12pt 0pt;">We are the only known provider of a non-magnetic intravenous (&#8220;IV&#8221;) infusion pump system specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium&#174; MRI compatible IV infusion pump system has a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is essential to critically ill patients who cannot be removed from their vital medications and children and infants who must generally be sedated to remain immobile during an MRI scan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;">Our 3880 MRI-compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient&#8217;s vital signs during various MRI procedures. The Iradimed 3880 system operates dependably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI scanner room. The Iradimed 3880 has a compact, lightweight design, allowing it to travel with the patient from the critical care unit to the MRI and back, resulting in increased patient safety through uninterrupted vital </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt 0pt 12pt 0pt;">signs monitoring and decreasing the amount of time critically ill patients are away from critical care units. The features of the Iradimed 3880 include wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo&#174; algorithms; non-magnetic respiratory CO2; invasive and non-invasive blood pressure; patient temperature, and optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The Iradimed 3880 MRI-compatible patient vital signs monitoring system has an easy-to-use design and allows for the effective communication of patient vital signs information to clinicians.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt 0pt 12pt 0pt;">For more information, please visit <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">www.iradimed.com</u>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:11pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Forward-Looking Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;">This release and any oral statements made regarding the subject of this release&#160;contain forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, that address activities that the Company assumes, plans, expects, believes, intends, projects, indicates, estimates or anticipates (and other similar expressions) will, should or may occur in the future are forward-looking statements, including statements relating financial guidance, future quarterly cash dividends, construction costs for the Company&#8217;s new facility in Orlando, Florida, and the Company&#8217;s strategic plans, objectives, and intentions. The forward-looking statements are based on management&#8217;s current belief, based on currently available information, as to the outcome and timing of future events. The forward-looking statements involve risks and uncertainties, including, among others, that our business plans may change as circumstances warrant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;">Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made, which reflect management&#8217;s current estimates, projections, expectations, or beliefs, and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to; potential disruptions in our limited supply chain for our products; the Company&#8217;s ability to receive U.S. Food and Drug Administration (&#8220;FDA&#8221;) 510(k)&#160;clearance for new products and product candidates; unexpected costs, delays or diversion of management&#8217;s attention associated with the design, manufacturing or sale of new products; the Company&#8217;s ability to implement successful sales techniques for existing and future products and evaluate the effectiveness of its sales techniques; additional actions, warnings or requests from the FDA or other regulatory bodies; our significant reliance on a limited number of products; a reduction in international distribution; actions of the FDA or other regulatory bodies that could delay, limit or suspend product development, manufacturing or sales; the effect of recalls, patient adverse events or deaths on our business; difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services; and changes in laws and regulations or in the interpretation or application of laws or regulations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;">Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of the Company&#8217;s control that could cause actual results to differ materially from the results discussed in the forward-looking statements. These risks, uncertainties, assumptions and other important factors include, but are not limited to, those included in Part II, Item 1A, &#8220;Risk Factors&#8221; of the Company&#8217;s Quarterly Reports on Form 10-Q, and Part I, Item 1A, &#8220;Risk Factors&#8221; of the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31,&#160;2024, as well as those otherwise described or updated from time to time in our other filings with the U.S. Securities and Exchange Commission. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and the Company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">IRADIMED CORPORATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">CONDENSED BALANCE SHEETS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 50,330,880</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 52,233,907</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 24,805,885</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 22,472,302</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 75,136,765</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 74,706,209</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 20,377,795</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 16,810,797</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 6,214,875</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 6,808,769</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 101,729,435</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 98,325,775</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accounts payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 2,590,044</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 1,896,405</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 2,598,549</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 2,259,616</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 3,284,851</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,356,287</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 8,473,444</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 8,512,308</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Deferred revenue, non-current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 3,201,561</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 2,993,287</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating lease liability, non-current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 1,424</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 11,675,005</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 11,507,019</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stockholders&#8217; equity:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total stockholders&#8217; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 90,054,430</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 86,818,756</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total liabilities and stockholders&#8217; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 101,729,435</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 98,325,775</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">IRADIMED CORPORATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">CONDENSED STATEMENTS OF OPERATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Unaudited)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 19,510,637</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 17,598,119</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cost of revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,667,831</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,210,396</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 14,842,806</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 13,387,723</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating expenses:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,610,832</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 3,991,211</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,176,273</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 3,827,165</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 624,245</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 821,000</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 9,411,350</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 8,639,376</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Income from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 5,431,456</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,748,347</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other income, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 513,973</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 495,154</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Income before provision for income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 5,945,429</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 5,243,501</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for income tax expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 1,258,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 1,106,968</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,687,429</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,136,533</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Basic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 0.37</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 0.33</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 0.37</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 0.32</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average shares outstanding:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Basic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 12,714,224</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 12,662,526</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 12,825,672</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 12,749,973</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">IRADIMED CORPORATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">RECONCILIATION OF NON-GAAP FINANCIAL MEASURES </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">(Unaudited)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Non-GAAP Net Income and Diluted EPS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:37.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:59.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:37.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,687,429</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,136,533</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Excluding:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Stock-based compensation expense, net of tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 654,243</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 496,626</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Non-GAAP net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 5,341,672</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,633,159</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted-average shares outstanding &#8211; diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 12,825,672</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 12,749,973</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-GAAP net income per share &#8211; diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 0.42</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 0.36</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Non-GAAP Free Cash Flow</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:41.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:54.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:41.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net cash provided by operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 4,292,092</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 3,883,155</font></p></td></tr><tr><td style="vertical-align:bottom;width:54.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Capital Expenditures</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 3,917,300</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 478,804</font></p></td></tr><tr><td style="vertical-align:bottom;width:54.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Free cash flow</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 374,792</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><font style="white-space:pre-wrap;"> 3,404,351</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:3pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Media Contact:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">IRADIMED CORPORATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(407) 677-8022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">InvestorRelations@iradimed.com</u></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>irmd-20250505xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irmd-20250505xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !  ;(# 2(  A$! Q$!_\0
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M(_B>/B/I/AS4_LITS["?$"0D)N^U>;Y7F_[L6['^S7Z!?\*+_9B_Z%3X=?\
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M3]ESXHWGC33O&.H:[/=6$MD]K=6B1+\[JV[<K?[%71Q$84ZL9?: XS_@L?\
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MR6O^W7V'X4OM=U3_ ()HW=SXE,CZO+\.+\L]P/G>/[%+Y3-_O1>6?QK\X_\
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MJ>IQJ\$!\U&EWJT4HYB\Q?N-][\OE$?!O]O<'_DNW@C_ ,%D'_RMKU']AO\
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988->DX!I>E=>(Q<\1&,9_9 6BBBN,#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>irmd-20250505.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.10.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/1/2025 9:43:18 PM-->
<!--Modified on: 5/1/2025 9:43:18 PM-->
<xsd:schema targetNamespace="http://iradimed.com/20250505" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:srt="http://fasb.org/srt/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:attributeFormDefault="unqualified" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:irmd="http://iradimed.com/20250505" xmlns:rxp="http://xbrl.sec.gov/rxp/2024q3" xmlns:snj="http://xbrl.sec.gov/snj/2024" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:cyd-8k-sub="http://xbrl.sec.gov/cyd-8k-sub/2024" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2024">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://iradimed.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="irmd-20250505_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="irmd-20250505_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>irmd-20250505_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.10.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/1/2025 9:43:18 PM-->
<!--Modified on: 5/1/2025 9:43:18 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address State Or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>irmd-20250505_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.10.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/1/2025 9:43:18 PM-->
<!--Modified on: 5/1/2025 9:43:18 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="irmd-20250505.xsd#DocumentDocumentAndEntityInformation" roleURI="http://iradimed.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://iradimed.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638817325983666253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638817325983666253" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638817325983666253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638817325983666253" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638817325983666253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638817325983666253" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638817325983666253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638817325983666253" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638817325983666253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638817325983666253" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638817325983666253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638817325983666253" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638817325983666253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638817325983666253" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638817325983677117" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638817325983677117" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638817325983677117" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638817325983677117" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638817325983677117" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638817325983677117" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638817325983677117" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638817325983677117" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638817325983677117" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638817325983677117" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638817325983677117" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638817325983677117" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638817325983677117" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638817325983677117" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638817325983677117" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638817325983677117" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638817325983686328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638817325983686328" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638817325983686328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638817325983686328" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638817325983686328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638817325983686328" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638817325983686328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638817325983686328" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638817325983686328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638817325983686328" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638817325983686328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638817325983686328" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638817325983696232" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638817325983696232" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  05,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IRADIMED CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001325618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">73-1408526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1025 Willa Springs Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Winter Springs<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">32708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">677-8022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IRMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  @XI5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    (  @XI5I7'L+E[0   "L"   1
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    (  @XI5J7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ "#BE6APX9>H_ 0
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M 5!+ 0(4 Q0    (  @XI5I&QTU(E0   ,T    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ "#BE6E<>PN7M    *P(
M !$              ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ "#BE6IE<G",0!@  G"<  !,              ( !WP$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    "  (.*5:JLO,OE4$  "N$   &
M        @($@"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ "#BE6I^@&_"Q @  X@P   T              ( !JPP  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    "  (.*5:EXJ[',     3 @  "P
M@ &'#P  7W)E;',O+G)E;'-02P$"% ,4    "  (.*5:'#AEZC\!   \ @
M#P              @ %P$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M"#BE6B0>FZ*M    ^ $  !H              ( !W!$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ "#BE6F60>9(9 0  SP,  !,
M             ( !P1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  "Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="irmd-20250505x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://iradimed.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>irmd-20250505.xsd</File>
    <File>irmd-20250505_lab.xml</File>
    <File>irmd-20250505_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="irmd-20250505x8k.htm">irmd-20250505x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "irmd-20250505x8k.htm": {
   "nsprefix": "irmd",
   "nsuri": "http://iradimed.com/20250505",
   "dts": {
    "schema": {
     "local": [
      "irmd-20250505.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "irmd-20250505_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "irmd-20250505_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "irmd-20250505x8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://iradimed.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "irmd-20250505x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "irmd-20250505x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://iradimed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001558370-25-006220-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-25-006220-xbrl.zip
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M);P6CYG#>^.(U^XC-H8[-$T[_3'T^E[R\T]FRSCL=NOFIX]]X/NXK#$6AN3
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M2?D(S>1<F,9R [#,ERYTGW#GQ(2LBJ&GHJ1Y7U-L5QD]S8"7*6W/R <=A\$
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MCM-.ZP6>X+7(>G6.4LW+=N;%;-:ME06F:F*V,S%6W6BI>5'SHN;EZ89LY3*
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M__/_!U!+ 0(4 Q0    (  @XI5H36O?OMP,  &,-   1              "
M 0    !I<FUD+3(P,C4P-3 U+GAS9%!+ 0(4 Q0    (  @XI5H">7<_< 4
M .P[   5              "  >8#  !I<FUD+3(P,C4P-3 U7VQA8BYX;6Q0
M2P$"% ,4    "  (.*5:MAJB1Y\$  #R)@  %0              @ &)"0
M:7)M9"TR,#(U,#4P-5]P<F4N>&UL4$L! A0#%     @ "#BE6I8DU=P\%
M+)   !0              ( !6PX  &ER;60M,C R-3 U,#5X.&LN:'1M4$L!
M A0#%     @ "#BE6KDF Y_O+@  CFD" !@              ( !R2(  &ER
L;60M,C R-3 U,#5X97@Y.60Q+FAT;5!+!08     !0 % $T!  #N40     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>irmd-20250505x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="irmd-20250505.xsd" xlink:type="simple"/>
    <context id="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001325618</identifier>
        </entity>
        <period>
            <startDate>2025-05-05</startDate>
            <endDate>2025-05-05</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Tc_3KoFK2MkSkayLYDGVyHvAg_2_1">0001325618</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Tc_Fhj_rzFGMkac7uhhMqR3JA_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_f2Rh0WnCDk2HKrE_m3L2JQ">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_YOzAUF8b8E-dlyvu4rxqpw">2025-05-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_GmUgadrvnU2fF17iBzsPpg">IRADIMED CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_MDEpSYTyQkiu6A32Nm2QWg">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Tc_Gy89x8je9EqHZI8jVFq8PA_1_0">001-36534</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Tc_XPqkCR46pkOYJTtE7bb9TQ_1_2">73-1408526</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_rndXxqiARUuRfIsn8VpQNA">1025 Willa Springs Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_4kl5514mFEa0jHVUf42a5A">Winter Springs</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_AP_3tyOyqkmUlKP9iXnURQ">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Tc_M3OI336MD0upp-GSCcCUpw_1_2">32708</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_Pmo3-xmPvE-SNrGsJV6XMA">407</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_xCBTYHZ6406gK2m9H8Qxmw">677-8022</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_dRms-T1pjkq-Qmjn7V3egQ">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_sHgmVo-xLESiFQImnfMY5g">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_Es9eBHYCAUuAXawO-lwFyw">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_mVWeQhlXqk6kZdLAQaFD_w">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_OUXgh8BOfEedgdMcldFftA">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Tc_rm_jkERcnkuq3HHcNNccMw_2_0">Common stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Tc_-T-9IaphNkSGnnxECrOfnA_2_2">IRMD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_5_5_2025_To_5_5_2025_H2fJyHXPf06F4y7MhWX41w"
      id="Narr_HNHP4WQkKkSHFQm1e7l26w">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
